UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Delcath Systems, Inc. of Class Action Lawsuit and the Deadline of July 8, 2013 to Seek a Lead Plaintiff Position NEW YORK, July 1, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Delcath Systems, Inc. ("Delcath" or the "Company") (Nasdaq:DCTH) stock between April 21, 2010 through May 2, 2013. For more information, click here: http://zlk.9nl.com/delcath-systems-dcth/. The complaint alleges that during the Class Period, Delcath Systems made false and/or misleading statements and/or failed to disclose that: (a) the Company's Melblez Kit for the treatment of patients with unresectable ocular melanoma metastatic to the liver included the risk of severe toxicity and death as a result of patient's adverse reactions to the drug; and (b) the Company's manufacturing facilities were in violation of Current Good Manufacturing Practices. On April 30, 2013, the FDA published documents revealing that 7% of the 122 patients treated with the Melblez Kit had died as a result of the treatment. On this news, shares of Delcath fell more than 40 percent. Then, on May 2, 2013, the Company announced that the ODAC voted unanimously that the benefits of the Kit did not outweigh the risks associated with the procedure. Upon this news, shares of Delcath System's fell further, to close at $0.46 per share the following day. If you suffered a loss in Delcath Systems you have until July 8, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (877) 363-5972, or visit http://zlk.9nl.com/delcath-systems-dcth/. Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (866) 367-6510 www.zlk.com
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Delcath Systems, Inc. of Class Action
Press spacebar to pause and continue. Press esc to stop.